SOPs for Analytical Method Development V 2.0

This SOP provides detailed instructions for the development, optimization, and validation of oxidation-reduction (redox) titration methods used for the quantitative analysis of redox-active pharmaceutical substances.
Click to read the full article.

The purpose of this SOP is to establish a procedure for the development and validation of analytical methods based on gas evolution reactions. These methods involve quantification of analytes that release a measurable gas (e.g., CO2, O2, H2) as part of their chemical reaction with specific reagents.
Click to read the full article.

This SOP establishes the procedure for the development, optimization, and validation of methods to determine moisture content in hygroscopic Active Pharmaceutical Ingredients (APIs). The methods include Karl Fischer (KF) titration, loss on drying (LOD), and thermogravimetric analysis (TGA), depending on API characteristics and moisture levels.
Click to read the full article.

This SOP outlines the procedure for developing and validating flame test methods for the qualitative identification of metal ions in pharmaceutical materials by observing characteristic color emissions upon combustion.
Click to read the full article.

The purpose of this SOP is to define the procedure for the development, optimization, and validation of gravimetric analytical methods for determining the purity of pharmaceutical substances based on quantitative precipitation and weighing of analyte-derived products.
Click to read the full article.

This SOP outlines the methodology for developing and validating refractive index (RI)-based analytical methods to qualitatively identify or quantitatively determine the concentration or purity of pharmaceutical compounds, primarily for substances that are colorless or dissolved in aqueous or organic solvents.
Click to read the full article.

This SOP defines the systematic procedure for the development and validation of analytical methods based on electrical conductivity. These methods are used for evaluating the ionic strength, purity, and quality of pharmaceutical substances and formulations.
Click to read the full article.

This SOP outlines the standardized procedure for developing, optimizing, and validating High-Performance Liquid Chromatography (HPLC) methods for quantitative and qualitative analysis of Active Pharmaceutical Ingredients (APIs) to ensure reliability, accuracy, and regulatory compliance.
Click to read the full article.

This SOP establishes a systematic and regulatory-compliant approach for the development and validation of HPLC methods for finished pharmaceutical dosage forms. The procedure is intended to support quantitative assay, content uniformity, dissolution profiling, and impurity determination in tablets, capsules, liquids, and injectables.
Click to read the full article.

This SOP describes the standardized procedure for developing and validating HPLC gradient methods for the separation, quantification, and identification of multiple analytes or impurities in complex pharmaceutical matrices. Gradient elution is essential where isocratic elution fails to achieve required resolution within an acceptable run time.
Click to read the full article.